Chinese perspective on end-of-life communication: a systematic review

JKH Pun, KM Cheung, JCH Chow… - BMJ Supportive & …, 2020 - spcare.bmj.com
Background Palliative care providers serving Chinese patients lack a culture-specific model
of communication, a strong evidence base for this and clear guidance on its application …

The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification

VHF Lee, DLW Kwong, TW Leung… - … journal of cancer, 2019 - Wiley Online Library
The eighth edition of the American Joint Committee on Cancer (AJCC)/Union for
International Cancer Control (UICC) stage classification (TNM) for nasopharyngeal …

Chemotherapy at end-of-life: an integration of oncology and palliative team

W Chan, K Lam, W Siu, K Yuen - Supportive Care in Cancer, 2016 - Springer
Palliative chemotherapy is increasingly used in cancer patients near end of life. With the
development of newer anticancer agents which have less side effects and higher expected …

Third-line systemic treatment versus best supportive care for advanced/metastatic gastric cancer: a systematic review and meta-analysis

W Chan, K Yuen, SW Siu, K Lam, DL Kwong - Critical Reviews in Oncology …, 2017 - Elsevier
This review evaluated the efficacy, toxicities and quality of life of third-line systemic treatment
(TLT) versus best supportive care (BSC) in metastatic gastric cancer patients after failing two …

[HTML][HTML] Acceptance of COVID-19 vaccination in cancer patients in Hong Kong: approaches to improve the vaccination rate

WL Chan, YHT Ho, CKH Wong, HCW Choi, KO Lam… - Vaccines, 2021 - mdpi.com
Emerging efficacy and safety data have led to the authorization of COVID-19 vaccines
worldwide, but most trials excluded patients with active malignancies. This study evaluates …

SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong

CH Lee, LY Mak, EHM Tang, DTW Lui, JHC Mak… - Hepatology, 2023 - journals.lww.com
SGLT2i reduces risk of developing HCC in patients with co-ex... : Hepatology SGLT2i reduces
risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A …

[HTML][HTML] Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma

TH So, SK Chan, WL Chan, H Choi, CL Chiang… - Advances in radiation …, 2020 - Elsevier
Purpose We hypothesized that radiation-induced lymphopenia could be predicted by the
effective dose to the circulating immune cells (EDIC) in advanced esophageal squamous …

[HTML][HTML] Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma

VHF Lee, DLW Kwong, TW Leung, CW Choi, V Lai… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract Plasma Epstein-Barr virus (EBV) DNA titers have been used to monitor treatment
response and provide prognostic information on survival for nasopharyngeal carcinoma …

Health-related quality of life in Asian differentiated thyroid cancer survivors

WL Chan, HCW Choi, B Lang, KP Wong… - Cancer …, 2021 - journals.sagepub.com
Background: Health-related quality of life (HRQoL) is important for differentiated thyroid
cancer survivors, but data for Asian survivors is lacking. This study aimed to have an …

[HTML][HTML] Return to work and work productivity during the first year after cancer treatment

SCY So, DWL Ng, Q Liao, R Fielding, I Soong… - Frontiers in …, 2022 - frontiersin.org
Objectives Working-age cancer patients face barriers to resuming work after treatment
completion. Those resuming work contend with reduced productivity arising from persisting …